Complement-Dependent Cytotoxicity Crossmatch Positive (CDCXM+) Transplantation: Current Practice and Outcomes

被引：0
|
作者：
Graff, R. [1 ]
Xiao, H. [1 ]
Tuttle-Newhall, J. [1 ]
Johnson, M. [2 ]
Lentine, K. [1 ]
机构：
[1] St Louis Univ, St Louis, MO 63103 USA
[2] Washington Univ, St Louis, MO 63130 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
885
引用
收藏
页码：292 / 293
页数：2
相关论文
共 50 条
  • [21] Discovery of microRNAs regulating complement-dependent cytotoxicity
    Hillman, Yaron
    Mardamshina, Mariya
    Geiger, Tamar
    Shomron, Noam
    Fishelson, Zvi
    [J]. MOLECULAR IMMUNOLOGY, 2017, 89 : 150 - 150
  • [22] The clinical significance of conversion of complement-dependent cytotoxic T cell crossmatch test after renal transplantation
    Kyllönen, LEJ
    Salmela, KT
    Koskimies, SA
    [J]. TRANSPLANT INTERNATIONAL, 1999, 12 (06) : 423 - 428
  • [23] Comparison of Complement-dependent Cytotoxic and Flow-cytometry Crossmatch Results Before Cadaveric Kidney Transplantation
    Ayna, T. K.
    Soyoz, M.
    Kurtulmus, Y.
    Dogan, S. M.
    Ozyilmaz, B.
    Tugmen, C.
    Pirim, I.
    [J]. TRANSPLANTATION PROCEEDINGS, 2013, 45 (03) : 878 - 880
  • [24] COMPARING COMPLEMENT DEPENDENT CYTOTOXICITY CROSSMATCH RESULTS WITH FLOW CYTOMETRIC CROSSMATCH RESULTS
    Basturk, Bilkay
    Kantaroglu, Bircan
    Sozer, Oktay
    Caliskan, Kenan
    [J]. TISSUE ANTIGENS, 2013, 81 (05): : 321 - 322
  • [25] Intravenous immunoglobulin and Thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients
    Akalin, E
    Ames, S
    Sehgal, V
    Fotino, M
    Daly, L
    Murphy, B
    Bromberg, JS
    [J]. TRANSPLANTATION, 2003, 76 (10) : 1444 - 1447
  • [26] Successful kidney transplantation across a positive complement-dependent cytotoxicity crossmatch by using C1q assay-directed, bortezomib-assisted desensitization A case report
    Lee, Juhan
    Park, Borae G.
    Jeong, Hyang Sook
    Park, Youn Hee
    Kim, Sinyoung
    Kim, Beam Seok
    Kim, Hye Jin
    Huh, Kyu Ha
    Jeong, Hyeon Joo
    Kim, Yu Seun
    [J]. MEDICINE, 2017, 96 (39)
  • [27] Very low residual concentrations of rituximab long after infusion still induce positive B-cell complement-dependent cytotoxicity-crossmatch
    Gatault, Philippe
    Jollet, Isabelle
    Paintaud, Gilles
    Magdelaine, Charlotte
    Bridoux, Franck
    Lebranchu, Yvon
    Buechler, Matthias
    Touchard, Guy
    Thierry, Antoine
    [J]. HUMAN IMMUNOLOGY, 2013, 74 (12) : 1616 - 1618
  • [28] Persistence of donor specific anti-HLA antibodies after complement dependent cytotoxicity crossmatch positive kidney transplantation.
    Gloor, M
    DeGoey, SR
    Winters, JL
    Lager, DJ
    Moore, SB
    Stegall, MD
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 253 - 253
  • [29] No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients
    Christiaans, MHL
    Overhof, R
    tenHaaft, A
    Nieman, F
    vanHooff, JP
    vandenBergLoonen, EM
    [J]. TRANSPLANTATION, 1996, 62 (09) : 1341 - 1347
  • [30] Belatacept does not mediate complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicity
    Davis, Patricia M.
    Nadler, Steven G.
    Suchard, Suzanne J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 619 - 619
12345